Summary : Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a loss of $277.4 million in its second quarter. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.62 per share. Nine analysts surveyed by Zacks expected $258.7 million. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.
<<<<<<<<<<<<<<<<<<<<
